AstraZeneca To Pay $520M In Seroquel Off-Label Case
AstraZeneca Pharmaceuticals LP has agreed to pay $520 million to settle an investigation by the U.S. Attorney's Office for the Eastern District of Pennsylvania into sales and marketing practices for the...To view the full article, register now.
Already a subscriber? Click here to view full article